-
Afternoon Gainers; Dendreon up Nearly 20%
Monday, August 15, 2011 - 3:42pm | 98Dendreon (NASDAQ: DNDN) +19.75% on a positive blog post regarding J and Q codes. VirnetX (NYSE: VHC) +19.73% on positive comments by Cowen. Velti (NASDAQ: VELT) +13.53 - hearing the company was mentioned positively by ThinkEquity. SemGroup (NASDAQ: SEMG) +10.09% after the company announced its...
-
Friday's Biotech/Pharma Stocks Trading
Monday, August 15, 2011 - 11:48am | 1475Point Roberts, WA - August 15, 2011 - Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks reports on trading and recent news for companies providing novel approaches to cancer therapy . In a roller coaster market of trading last week,...
-
Friday's NASDAQ Winners: Clearwire, Sky-Mobi, MannKind, TranSwitch
Monday, August 15, 2011 - 10:44am | 532POINT ROBERTS - August 15, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Aug. 12, 2011. Clearwire Corporation was leading the gainers list gainer in Friday's sessions as the stock moved over 20%....
-
MLV Maintains Buy on ArQule
Monday, August 15, 2011 - 9:27am | 92MLV is out with its report today on ArQule (NASDAQ: ARQL), maintaining Buy. in its report, MLV writes, "We have revised our model and now project that ArQule could become sustainably profitable in 2015 based on the launch of tivantinib for NSCLC and HCC (if results of the ongoing trials are...
-
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark
Monday, August 15, 2011 - 8:55am | 123Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on September 9, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May...
-
UPDATE: Rodman & Renshaw Upgrades Exact Sciences to Market Outperform
Monday, August 15, 2011 - 8:52am | 103Rodman & Renshaw is out with its report today on Exact Sciences (NASDAQ: EXAS), upgrading EXAS to Market Outperform from Market Perform. In its report, Rodman & Renshaw writes, "We are upgrading Exact Sciences from Market Perform to Market Outperform with an 18-month Target Price of $12/sh...
-
Gilead's Antiretroviral Regiment Meets 48-Week Primary Objective in Phase 3 Study
Monday, August 15, 2011 - 8:32am | 103Gilead Sciences, Inc. (Nasdaq: GILD) today announced that a Phase 3 clinical trial of its investigational fixed-dose, single-tablet “Quad” regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its...
-
Benzinga's Top Upgrades
Monday, August 15, 2011 - 8:25am | 130Analysts at Rodman & Renshaw upgraded Exact Sciences Corporation (NASDAQ: EXAS) from “market perform” to “market outperform.” EXAS' shares closed at $6.44 on Friday. Exact Sciences' trailing-twelve-month revenue is $4.81 million. Analysts at Goldman Sachs upgraded Family Dollar Stores Inc (...
-
Rodman & Renshaw Upgrades Exact Sciences To Market Outperform, $12 PT
Monday, August 15, 2011 - 7:35am | 28Rodman & Renshaw has upgraded Exact Sciences (NASDAQ: EXAS) from Market Perform to Market Outperform and has established a $12 price target.
-
Piper Jaffray Reiterates Overweight Rating On Regeneron Pharmaceuticals
Monday, August 15, 2011 - 7:33am | 99According to Piper Jaffray, Regeneron Pharmaceuticals (NASDAQ: REGN) Overweight rating is reiterated. Piper Jaffray said that it remains buyers of REGN shares this week into likely approval of EYLEA in wet Age-related Macular Degeneration (AMD) by Saturday's August 20th PDUFA date. “We reiterate...
-
Earnings Scheduled For August 15
Monday, August 15, 2011 - 1:05am | 509Sysco Corporation (NYSE: SYY) is projected to report its Q4 EPS at $0.57 on revenue of $10.36 billion. Estee Lauder Companies Inc (The) (NYSE: EL) is estimated to report its Q4 EPS at $0.24 on revenue of $2.03 billion. 3SBio Inc (NASDAQ: SSRX) is expected to post its Q2 EPS at $0.20 on revenue of...
-
Can You Help Save Mannkind?
Friday, August 12, 2011 - 6:21pm | 483One small-cap company that is involved in biotech research and development is MannKind (NASDAQ: MNKD). MannKind has been operating since 2001, focusing primarily on cancer and diabetes drug development. Since January 2011, the company's stock has dropped from nearly $10 to below $3, outlining the...
-
Can You Help Save Mannkind?
Friday, August 12, 2011 - 6:17pm | 483One small-cap company that is involved in biotech research and development is MannKind (NASDAQ: MNKD). MannKind has been operating since 2001, focusing primarily on cancer and diabetes drug development. Since January 2011, the company's stock has dropped from nearly $10 to below $3, outlining the...
-
Can You Help Save Mannkind?
Friday, August 12, 2011 - 6:17pm | 483One small-cap company that is involved in biotech research and development is MannKind (NASDAQ: MNKD). MannKind has been operating since 2001, focusing primarily on cancer and diabetes drug development. Since January 2011, the company's stock has dropped from nearly $10 to below $3, outlining the...
-
Thursday's NASDAQ Winners: A123 Systems, Telik, AsiaInfo-Linkage, PositiveID
Friday, August 12, 2011 - 11:28am | 527POINT ROBERTS - August 12, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Aug. 11, 2011. Renewable energy stock, A123 Systems was the top gainer in Thursday's sessions as the stock witnessed a gain of...